The abstract is read at the publisher; the summary is JClub's.
Bromoxynil, identified from German BfR long-term rodent pesticide studies, increased survival at termination by at least 10% (p < 0.05) and improved multiple healthspan indicators in Caenorhabditis elegans without harming organismal health.
- Why it matters: Human translation of longevity interventions requires mammalian in vivo efficacy and safety, but controlled lifespan studies are slow and low-throughput, making hormetic dose-response testing difficult.
- What they did: The authors mined a random subset of the German Federal Institute for Risk Assessment archive for long-term rodent pesticide studies with ≥ 50 animals per dose and sex, then back-translated candidates to Caenorhabditis elegans and tested mitochondrial oxygen consumption in mammalian cells.
- The result: From 154 qualifying substances, 27 (18%) significantly increased survival at termination (≥ 10%, p < 0.05); about half affected mitochondrial oxygen consumption, and bromoxynil acted as a mitochondrial uncoupler.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.